Related Articles
REIC/Dkk-3 as a potential gene therapeutic agent against human testicular cancer
Expression pattern of REIC/Dkk-3 in various cell types and the implications of the soluble form in prostatic acinar development
The cysteine-rich core domain of REIC/Dkk-3 is critical for its effect on monocyte differentiation and tumor regression
Tumor suppressor REIC/Dkk‑3 and its interacting protein SGTA inhibit glucocorticoid receptor to nuclear transport
Preclinical biodistribution and safety study of reduced expression in immortalized cells/Dickkopf-3-encoding adenoviral vector for prostate cancer gene therapy